PROCTER & GAMBLE HEALTH
Quarterly Results Analysis [Dec2024]
PROCTER & GAMBLE HEALTH Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 Audited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹310 Cr | ₹313 Cr | ₹284 Cr | ₹252 Cr | ₹310 Cr | ₹305 Cr | ₹301 Cr | ₹321 Cr |
Expenses | ₹186 Cr | ₹199 Cr | ₹236 Cr | ₹185 Cr | ₹208 Cr | ₹216 Cr | ₹256 Cr | ₹241 Cr |
Operating Income | ₹123 Cr | ₹114 Cr | ₹48 Cr | ₹67 Cr | ₹102 Cr | ₹89 Cr | ₹45 Cr | ₹80 Cr |
Other Income | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr |
Profit Before Tax | ₹122 Cr | ₹111 Cr | ₹23 Cr | ₹63 Cr | ₹100 Cr | ₹88 Cr | ₹44 Cr | ₹79 Cr |
Profit After Tax | ₹91 Cr | ₹82 Cr | ₹17 Cr | ₹47 Cr | ₹72 Cr | ₹66 Cr | ₹30 Cr | ₹59 Cr |
EPS | ₹54.76 | ₹49.60 | ₹10.11 | ₹28.05 | ₹43.42 | ₹39.50 | ₹17.96 | ₹35.66 |
Industry Peers & Returns | 1W | 1M | 1Y |
PROCTER & GAMBLE HEALTH | -1.2% | 5.4% | 9.5% |
SUN PHARMACEUTICAL INDUSTRIES | -2.5% | 7.6% | 4.7% |
DIVIS LABORATORIES | -3% | 3.4% | 61.5% |
CIPLA | -1.6% | 3% | -3.4% |
TORRENT PHARMACEUTICALS | -0.3% | 9% | 22.3% |
DR REDDYS LABORATORIES | -1.2% | 2.9% | -6.4% |
MANKIND PHARMA | 0.6% | 5.7% | 6.9% |
ZYDUS LIFESCIENCES | -1.7% | 1.7% | -12.7% |
LUPIN | -2.4% | 5.4% | 20.9% |
PROCTER & GAMBLE HEALTH Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.16 % |
Y-o-Y | -0.06 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹310 Cr | -1.16 | |
Sep2024 | ₹313 Cr | 10.40 | |
Jun2024 | ₹284 Cr | 12.44 | |
Mar2024 | ₹252 Cr | -18.55 | |
Dec2023 | ₹310 Cr | 1.65 | |
Sep2023 | ₹305 Cr | 1.25 | |
Jun2023 | ₹301 Cr | -6.15 | |
Mar2023 | ₹321 Cr | - |
PROCTER & GAMBLE HEALTH Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 8.23 % |
Y-o-Y | 21.43 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹123 Cr | 8.23 | |
Sep2024 | ₹114 Cr | 136.35 | |
Jun2024 | ₹48 Cr | -28.45 | |
Mar2024 | ₹67 Cr | -33.65 | |
Dec2023 | ₹102 Cr | 14.65 | |
Sep2023 | ₹89 Cr | 95.54 | |
Jun2023 | ₹45 Cr | -43.08 | |
Mar2023 | ₹80 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 9.51 % |
Y-o-Y | 21.53 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 39.85% | 9.51 | |
Sep2024 | 36.39% | 114.06 | |
Jun2024 | 17% | -36.35 | |
Mar2024 | 26.71% | -18.54 | |
Dec2023 | 32.79% | 12.76 | |
Sep2023 | 29.08% | 93.22 | |
Jun2023 | 15.05% | -39.36 | |
Mar2023 | 24.82% | - |
PROCTER & GAMBLE HEALTH Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 10.41 % |
Y-o-Y | 26.13 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹91 Cr | 10.41 | |
Sep2024 | ₹82 Cr | 390.64 | |
Jun2024 | ₹17 Cr | -63.96 | |
Mar2024 | ₹47 Cr | -35.40 | |
Dec2023 | ₹72 Cr | 9.91 | |
Sep2023 | ₹66 Cr | 119.89 | |
Jun2023 | ₹30 Cr | -49.62 | |
Mar2023 | ₹59 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 11.69 % |
Y-o-Y | 26.19 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 29.34 % | 11.69 | |
Sep2024 | 26.27 % | 344.50 | |
Jun2024 | 5.91 % | -67.95 | |
Mar2024 | 18.44 % | -20.69 | |
Dec2023 | 23.25 % | 8.14 | |
Sep2023 | 21.5 % | 117.17 | |
Jun2023 | 9.9 % | -46.31 | |
Mar2023 | 18.44 % | - |
PROCTER & GAMBLE HEALTH Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 10.40 % |
Y-o-Y | 26.12 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹54.76 | 10.40 | |
Sep2024 | ₹49.6 | 390.60 | |
Jun2024 | ₹10.11 | -63.96 | |
Mar2024 | ₹28.05 | -35.40 | |
Dec2023 | ₹43.42 | 9.92 | |
Sep2023 | ₹39.5 | 119.93 | |
Jun2023 | ₹17.96 | -49.64 | |
Mar2023 | ₹35.66 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD